Compared to non-CYP3A4 metabolized statin plus clopidogrel, the CYP-3A4 metabolized statin therapy combined clopidogrel failed to reduce the incidence of stroke (RR 0.86; 95% CI 0.13,5.61; p = 0.875). Here, CYP3A4 is linked to Stroke.